Aarti Drugs Ltd Q4, FY2020 results on May 15th
Aarti Drugs Ltd Q4:
The Aarti Drugs Ltd’s Board of Directors meeting scheduled for May 15th, to review and approve the audited financial results for the quarter and year ended 31 March.
The total number of shares traded in over 943 trades during the day was 5234. The stock hit a Rs 784 intraday high, and a Rs 736.6 intraday low. Net sales Rs 4018257 during the day.
Besides on May 8th, the share of Aarti Drugs Ltd traded with the bearish trend. It traded with a loss of 16.90 points reached 744.00 INR with 2.22% down in NSE. Whereas in BSE, it traded with a loss of 19.85 points reached 741.30 INR with 2.61% down. Meanwhile, its previous close at Rs 761.15.
Stock Market on May 8th:
On the fifth day of the week, the stock market traded with the bullish trend. The Sensex traded with a gain of 199.32 points reached 31,642.70 level with 0.63% up. Whereas, Nifty traded with a gain of 52.45 points reached 9,251.50 level with 0.57% up.
In the border market, the S&P BSE Midcap traded with a gain of 4.13 points reached 11,423.81 with 0.036% up. Whereas, S&P BSE SmallCap traded with a loss of 48.05 points reached 10,638.70 with 0.45% down. At the same time, Nifty bank traded with a loss of 138.90 points reached 19,352.90 with 0.71% down.
Top Gainers: Hindustan Unilever, Sun Pharmaceutical Industries, Dr.Reddy’s Laboratories, Tech Mahindra, and Nestle India Limited.
Top Losers: NTPC, Mahindra & Mahindra, Axis Bank, Indusind Bank, and JSW Steel Limited.
